Ilant Health, a NYC-based provider of obesity management and cardiometabolic health solutions, raised additional $3M in funding.
The round, which brought the total amount to $5.5M, saw participation from LifeX Ventures, Celtic House Asia Partners, and Cornucopian Capital, as well as existing investors.
The company intends to use the funds to expand operations and its development efforts.
Led by CEO Elina Onitskanky, Ilant Health is an obesity and cardiometabolic health company, focused on increasing access to treatment while reducing total cost of care for employers and payers through value-based care. It provides end-to-end evidence-based solutions (bariatric surgery, medication, intense behavioral therapy) through a technology-enabled and analytics-driven obesity medicine practice.
Ilant Health’s ongoing commercial traction is evident through the launch of clinical services to multiple employers and the use of its claims analytics for hundreds of thousands of lives on behalf of large health plans and employers. Its claims analytics, driven by unstructured machine learning, have provided insights around the potential to drive reductions in total cost of care and return on investment from obesity treatment.
Ilant supports its members in understanding and selecting optimal treatment options – many of which are not GLP-1s– and then provides integrated care through obesity medicine physicians, dietitians and mental health specialists.
As part of this raise, the company has also engaged prominent industry advisors, including Teri Wisness, former Director of U.S. Benefits at Google and Partner at Iron Street Advisors, and Meghan Fitzgerald, former executive at Cardinal Health and member of the Board of Directors at Tenet Healthcare.
FinSMEs
17/04/2024